113 related articles for article (PubMed ID: 17895124)
1. Emergency physician attitudes toward thrombolytic therapy in acute stroke.
Chaturvedi S; Bertasio B; Femino L
J Stroke Cerebrovasc Dis; 1998; 7(6):442-5. PubMed ID: 17895124
[TBL] [Abstract][Full Text] [Related]
2. Barriers to administering intravenous tissue plasminogen activator (tPA) for acute ischemic stroke in the emergency department: A cross-sectional survey of stroke centers.
Hargis M; Shah JN; Mazabob J; Rao CV; Suarez JI; Bershad EM
Clin Neurol Neurosurg; 2015 Aug; 135():79-84. PubMed ID: 26047090
[TBL] [Abstract][Full Text] [Related]
3. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
4. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.
Albers GW; Bates VE; Clark WM; Bell R; Verro P; Hamilton SA
JAMA; 2000 Mar; 283(9):1145-50. PubMed ID: 10703776
[TBL] [Abstract][Full Text] [Related]
5. Urgent carotid intervention is safe after thrombolysis for minor to moderate acute ischemic stroke.
Bazan HA; Zea N; Jennings B; Smith TA; Vidal G; Sternbergh WC
J Vasc Surg; 2015 Dec; 62(6):1529-38. PubMed ID: 26412434
[TBL] [Abstract][Full Text] [Related]
6. Stroke center characteristics which influence the administration of thrombolytic therapy for acute ischemic stroke: a national survey of stroke centers in Taiwan.
Jeng JS; Tang SC; Deng IC; Tsai LK; Yeh SJ; Yip PK
J Neurol Sci; 2009 Jun; 281(1-2):24-7. PubMed ID: 19362319
[TBL] [Abstract][Full Text] [Related]
7. Safety Outcomes After Thrombolysis for Acute Ischemic Stroke in Patients With Recent Stroke.
Merkler AE; Salehi Omran S; Gialdini G; Lerario MP; Yaghi S; Elkind MSV; Navi BB
Stroke; 2017 Aug; 48(8):2282-2284. PubMed ID: 28679847
[TBL] [Abstract][Full Text] [Related]
8. Drip and ship thrombolytic therapy for acute ischemic stroke: use, temporal trends, and outcomes.
Sheth KN; Smith EE; Grau-Sepulveda MV; Kleindorfer D; Fonarow GC; Schwamm LH
Stroke; 2015 Mar; 46(3):732-9. PubMed ID: 25672784
[TBL] [Abstract][Full Text] [Related]
9. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke.
Saposnik G; Fang J; Kapral MK; Tu JV; Mamdani M; Austin P; Johnston SC; ;
Stroke; 2012 May; 43(5):1315-22. PubMed ID: 22308252
[TBL] [Abstract][Full Text] [Related]
10. Lessons learned from 2 years experience in intravenous thrombolysis for acute ischemic stroke in a single tertiary medical center.
Gur AY; Shopin L; Bornstein NM
Isr Med Assoc J; 2009 Dec; 11(12):714-6, 718. PubMed ID: 20166336
[TBL] [Abstract][Full Text] [Related]
11. Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.
Liu S; Feng X; Jin R; Li G
Expert Opin Drug Deliv; 2018 Feb; 15(2):173-184. PubMed ID: 28944694
[TBL] [Abstract][Full Text] [Related]
12. Safety of Intravenous Thrombolysis among Stroke Patients Taking New Oral Anticoagulants--Case Series and Systematic Review of Reported Cases.
Shahjouei S; Tsivgoulis G; Bavarsad Shahripour R; Jones GM; Alexandrov AV; Zand R
J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2685-93. PubMed ID: 26542821
[TBL] [Abstract][Full Text] [Related]
13. National Practice Patterns of Obtaining Informed Consent for Stroke Thrombolysis.
Mendelson SJ; Courtney DM; Gordon EJ; Thomas LF; Holl JL; Prabhakaran S
Stroke; 2018 Mar; 49(3):765-767. PubMed ID: 29440586
[TBL] [Abstract][Full Text] [Related]
14. Current status of intravenous thrombolysis for acute ischemic stroke in Asia.
Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP
Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797
[TBL] [Abstract][Full Text] [Related]
15. Prehospital triage to primary stroke centers and rate of stroke thrombolysis.
Prabhakaran S; O'Neill K; Stein-Spencer L; Walter J; Alberts MJ
JAMA Neurol; 2013 Sep; 70(9):1126-32. PubMed ID: 23817961
[TBL] [Abstract][Full Text] [Related]
16. Thrombolytic therapy for acute ischemic stroke.
Canadian Association of Emergency Physicians Committee on Thrombolytic Therapy for Acute Ischemic Stroke
CJEM; 2001 Jan; 3(1):8-12. PubMed ID: 17612434
[TBL] [Abstract][Full Text] [Related]
17. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
Ong CT; Wong YS; Wu CS; Su YH
Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
[TBL] [Abstract][Full Text] [Related]
18. Thrombolytic therapy in cerebrovascular disorders.
Levine SR; Brott TG
Prog Cardiovasc Dis; 1992; 34(4):235-62. PubMed ID: 1728786
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute stroke in patients on dabigatran: a survey of US stroke specialists.
Rybinnik I; Mullen MT; Messe S; Kasner SE; Cucchiara B
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1312-6. PubMed ID: 23313461
[TBL] [Abstract][Full Text] [Related]
20. Role of tissue plasminogen activator in acute ischemic stroke.
Hatcher MA; Starr JA
Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
